Due to scheduled maintenance work, this service may not be available on Monday January 22nd between 08.00 am and 9.00 am CEST.
To improve security and privacy, we are moving our web pages and services from HTTP to HTTPS.
To give users of web services time to transition to HTTPS, we will support separate HTTP and HTTPS services until the end of 2017.
From January 2018 most HTTP traffic will be automatically redirected to HTTPS. [more...]
View this page in https
PROSITE documentation PDOC00445

Fibrinogen C-terminal domain signature and profile


Fibrinogen, the principal protein of vertebrate blood clotting is a hexamer containing two sets of three different chains (α, β, and γ), linked to each other by disulfide bonds [1,2]. The N-terminal sections of these three chains contain the cysteines that participate in the cross-linking of the chains. The C-terminal parts of the α, β and γ chains contain a domain of about 225 amino-acid residues, which can function as a molecular recognition unit [2,3,4,5,6]. In fibrinogen as well as in angiopoietin this domain is implicated in protein-protein interactions. In lectins, such as mammalian ficolins and invertebrate tachylectin 5A, the fibrinogen C-terminal domain binds carbohydrates. As shown in the schematic representation this domain contains four conserved cysteines involved in two disulfide bonds.

        |            |                                 |     |
        +------------+                                 +-----+
               A                    B               P
'C': conserved cysteine involved in a disulfide bond.
'*': position of the pattern.
'A,B,P': regions within the domain

The 3D structure of the fibrinogen C-terminal domain (see <PDB:1FZA; F>) shows a fold composed of three separate regions [2,5,6,7]. The N-terminal region, also termed A domain, forms a helix and a β-sheet held together by the first disulfide bond. The second region, or B domain, is the largest. The third region, also termed P domain, forms long extended coil regions and contains the C-terminal disulfide bond. This P region is the most divergent and contains most ligand binding sites and in some cases residues implicated in calcium binding.

Some proteins known to contain a fibrinogen C-terminal domain:

  • Vertebrate fibrinogen α, β and γ chains.
  • Mammalian tenascin-X, an extracellular matrix protein that mediates interactions between cells and the extracellular matrix and accelerates collagen fibril formation. The C-terminal fibrinogen domain binds with fibrillar proteins in the extracellular matrix.
  • Vertebrate angiopoietin proteins, which contain a C-terminal fibrinogen domain that interacts with tyrosine-protein kinase receptor TIE2.
  • Mammalian prothrombinase or fibroleukin.
  • Sea cucumber fibrinogen-like protein A.
  • Fruit fly protein scabrous (gene sca). Scabrous is involved in the regulation of neurogenesis in Drosophila and may encode a lateral inhibitor of R8 cells differentiation.
  • Horseshoe crab techylectin-5A, a nonself-recognizing lectin with a fibrinogen C-terminal domain that recognizes carbohydrates.
  • Mammalian ficolins, with a collagen-like domain and a C-terminal fibrinogen domain that contains potential calcium-binding sites and can interact with GlcNAc.

As a signature pattern for this domain, we selected the region around the fourth cysteine. We also developed a profile that covers the entire fibrinogen C-terminal domain.


In contactin-associated proteins (Cntnap/Caspr) and intelectins (Itln) only the N-terminal 'A' region of the fibrinogen C-terminal domain is well conserved and detected.

Expert(s) to contact by email:

Doolittle R.F.

Last update:

September 2008 / Text revised; profile added.

Technical section

PROSITE methods (with tools and information) covered by this documentation:

FIBRINOGEN_C_2, PS51406; Fibrinogen C-terminal domain profile  (MATRIX)

FIBRINOGEN_C_1, PS00514; Fibrinogen C-terminal domain signature  (PATTERN)


1AuthorsDoolittle R.F.
TitleFibrinogen and fibrin.
SourceAnnu. Rev. Biochem. 53:195-229(1984).
PubMed ID6383194

2AuthorsSpraggon G., Everse S.J., Doolittle R.F.
TitleCrystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
SourceNature 389:455-462(1997).
PubMed ID9333233

3AuthorsXu X., Doolittle R.F.
TitlePresence of a vertebrate fibrinogen-like sequence in an echinoderm.
SourceProc. Natl. Acad. Sci. U.S.A. 87:2097-2101(1990).
PubMed ID2315305

4AuthorsBaker N.E., Mlodzik M., Rubin G.M.
TitleSpacing differentiation in the developing Drosophila eye: a fibrinogen-related lateral inhibitor encoded by scabrous.
SourceScience 250:1370-1377(1990).
PubMed ID2175046

5AuthorsKairies N., Beisel H.G., Fuentes-Prior P., Tsuda R., Muta T., Iwanaga S., Bode W., Huber R., Kawabata S.
TitleThe 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems.
SourceProc. Natl. Acad. Sci. U.S.A. 98:13519-13524(2001).
PubMed ID11707569

6AuthorsBarton W.A., Tzvetkova-Robev D., Miranda E.P., Kolev M.V., Rajashankar K.R., Himanen J.P., Nikolov D.B.
TitleCrystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.
SourceNat. Struct. Mol. Biol. 13:524-532(2006).
PubMed ID16732286

7AuthorsKostelansky M.S., Lounes K.C., Ping L.F., Dickerson S.K., Gorkun O.V., Lord S.T.
TitleCalcium-binding site beta 2, adjacent to the 'b' polymerization site, modulates lateral aggregation of protofibrils during fibrin polymerization.
SourceBiochemistry 43:2475-2483(2004).
PubMed ID14992585

PROSITE is copyright. It is produced by the SIB Swiss Institute Bioinformatics. There are no restrictions on its use by non-profit institutions as long as its content is in no way modified. Usage by and for commercial entities requires a license agreement. For information about the licensing scheme send an email to
Prosite License or see: prosite_license.html.


View entry in original PROSITE document format
View entry in raw text format (no links)